Windtree Therapeutics Stock (NASDAQ: WINT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.000 / 15.016K |
Day Range | - - - |
52 Wk Range | 4.777 - 44.460 |
Market Cap | $2.857M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 7.81% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Windtree Therapeutics (NASDAQ: WINT) through any online brokerage.
Other companies in Windtree Therapeutics’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Geovax Labs (NASDAQ:GOVX) and Genprex (NASDAQ:GNPX).
The latest price target for Windtree Therapeutics (NASDAQ: WINT) was reported by HC Wainwright & Co. on Wednesday, January 3, 2024. The analyst firm set a price target for 1.00 expecting WINT to fall to within 12 months (a possible -82.14% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $5.6 last updated April 23, 2024 at 7:19 PM EDT.
There are no upcoming dividends for Windtree Therapeutics.
Windtree Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Windtree Therapeutics.
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.